Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
NCT ID: NCT05440487
Last Updated: 2022-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
489 participants
OBSERVATIONAL
2015-09-15
2021-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy
NCT01604941
Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy
NCT01874405
Multi-Center Study of Iron Overload: Pilot Study
NCT01114776
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload
NCT01186419
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
NCT00171821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Corresponding to the clinical routine, follow up visits can be documented after approximately 1, 3, 6, 9, 12 and 18 month with a close out visit after 24 month. In case the iron chelator is switched, the visit scheme should be passed through once again.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iron chelator
Patients prescribed with Iron Chelators
Iron chelator
There is no treatment allocation. Patients administered approved Iron chelators by prescription that have started before inclusion of the patient into the study will be enrolled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron chelator
There is no treatment allocation. Patients administered approved Iron chelators by prescription that have started before inclusion of the patient into the study will be enrolled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who never received an iron chelator directly before starting an iron chelation therapy
* who received an iron chelation therapy for less than 6 month
* who interrupted an iron chelation therapy for longer than 6 months and will receive an iron chelation therapy again
* who signed the informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Investigative Site
Heidenheim, Baden-Wurttemberg, Germany
Novartis Investigative Site
Mannheim, Baden-Wurttemberg, Germany
Novartis Investigative Site
Winnenden, Baden-Wurttemberg, Germany
Novartis Investigative Site
Aschaffenburg, Bavaria, Germany
Novartis Investigative Site
Bamberg, Bavaria, Germany
Novartis Investigative Site
Bayreuth, Bavaria, Germany
Novartis Investigative Site
Landshut, Bavaria, Germany
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Regensburg, Bavaria, Germany
Novartis Investigative Site
Garbsen, Lower Saxony, Germany
Novartis Investigative Site
Aachen, North Rhine-Westphalia, Germany
Novartis Investigative Site
Bonn, North Rhine-Westphalia, Germany
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site
Dortmund, North Rhine-Westphalia, Germany
Novartis Investigative Site
Duisburg, North Rhine-Westphalia, Germany
Novartis Investigative Site
Gelsenkirchen, North Rhine-Westphalia, Germany
Novartis Investigative Site
Iserlohn, Northrhine Westfalia, Germany
Novartis Investigative Site
Remscheid Innen, Northrhine Westfalia, Germany
Novartis Investigative Site
Neuwied, Rhineland-Palatinate, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Pirna, Saxony, Germany
Novartis Investigative Site
Zittau, Saxony, Germany
Novartis Investigative Site
Lübeck, Schleswig-Holstein, Germany
Novartis Investigative Site
Erfurt, Thuringia, Germany
Novartis Investigative Site
Altenburg, , Germany
Novartis Investigative Site
Bad Liebenwerda, , Germany
Novartis Investigative Site
Bad Mergentheim, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Biberach, , Germany
Novartis Investigative Site
Bochum, , Germany
Novartis Investigative Site
Bottrop, , Germany
Novartis Investigative Site
Bremerhaven, , Germany
Novartis Investigative Site
Celle, , Germany
Novartis Investigative Site
Chemnitz, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigative Site
Donauwörth, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Erfurt, , Germany
Novartis Investigative Site
Essen, , Germany
Novartis Investigative Site
Gera, , Germany
Novartis Investigative Site
Goslar, , Germany
Novartis Investigative Site
Göttingen, , Germany
Novartis Investigative Site
Halle, , Germany
Novartis Investigative Site
Hamelin, , Germany
Novartis Investigative Site
Hamm, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Heidelberg, , Germany
Novartis Investigative Site
Heilbronn, , Germany
Novartis Investigative Site
Herrsching am Ammersee, , Germany
Novartis Investigative Site
Hildesheim, , Germany
Novartis Investigative Site
Hildesheim, , Germany
Novartis Investigative Site
Hof, , Germany
Novartis Investigative Site
Kaiserslautern, , Germany
Novartis Investigative Site
Kassel, , Germany
Novartis Investigative Site
Kassel, , Germany
Novartis Investigative Site
Koblenz, , Germany
Novartis Investigative Site
Krefeld, , Germany
Novartis Investigative Site
Kronach, , Germany
Novartis Investigative Site
Lemgo, , Germany
Novartis Investigative Site
Lüdenscheid, , Germany
Novartis Investigative Site
Marburg, , Germany
Novartis Investigative Site
Minden, , Germany
Novartis Investigative Site
Moers, , Germany
Novartis Investigative Site
Mülheim, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Naunhof, , Germany
Novartis Investigative Site
Neuss, , Germany
Novartis Investigative Site
Neustadt, , Germany
Novartis Investigative Site
Nordhorn, , Germany
Novartis Investigative Site
Nuremberg, , Germany
Novartis Investigative Site
Nuremberg, , Germany
Novartis Investigative Site
Offenburg, , Germany
Novartis Investigative Site
Passau, , Germany
Novartis Investigative Site
Porta Westfalica, , Germany
Novartis Investigative Site
Potsdam, , Germany
Novartis Investigative Site
Riesa, , Germany
Novartis Investigative Site
Rostock, , Germany
Novartis Investigative Site
Rötha, , Germany
Novartis Investigative Site
Saarbrücken, , Germany
Novartis Investigative Site
Schorndorf, , Germany
Novartis Investigative Site
Schwäbisch Hall, , Germany
Novartis Investigative Site
Speyer, , Germany
Novartis Investigative Site
Stade, , Germany
Novartis Investigative Site
Stolberg, , Germany
Novartis Investigative Site
Stuttgart, , Germany
Novartis Investigative Site
Traunstein, , Germany
Novartis Investigative Site
Weiden, , Germany
Novartis Investigative Site
Wesel, , Germany
Novartis Investigative Site
Westerstede, , Germany
Novartis Investigative Site
Wittenberg, , Germany
Novartis Investigative Site
Wolfsburg, , Germany
Novartis Investigative Site
Würselen, , Germany
Novartis Investigative Site
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Results for CICL670ADE14 from the Novartis Clinical Trials Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CICL670ADE14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.